Leurubicin - CISMeF

Preferred Label : Leurubicin;

NCIt definition : An N-L-leucyl prodrug of the anthracycline doxorubicin, with antineoplastic activity. Leurubicin is converted to its active form doxorubicin in or on tumor cells by hydrolytic enzymes.;

UNII : 1Z20MGK851;

InChIKey : HROXIDVVXKDCBD-ZUWKMVCBSA-N;

CAS number : 70774-25-3; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 70774-25-3 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Chemical formula : C33H40N2O12;

Details

Origin ID

C81421;

UMLS CUI

C2825623;

Automatic exact mappings (from CISMeF team)
- N-leucyldoxorubicin [MeSH concept]
- N-leucyldoxorubicin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients